Amtek Laboratories Limited

Amtek Laboratories Limited - chemicals and materials in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U74899DL1994PLC062969 Incorporated 24 November 1994 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2020
₹25.21 Lakh
Latest filing
EBITDA · FY 2020
*****
▼ 187245.00% YoY
Net profit · FY 2020
*****
▼ 180003.00% YoY
Authorised capital
₹22.7 Cr
Registered with MCA
Paid-up capital
₹22.69 Cr
Issued & subscribed
Open charges
₹10 Cr
Secured borrowings
Company age
32 yrs
Est. 1994
Last financials
Mar 2020
Balance sheet date

About Amtek Laboratories Limited

Data last updated: 11 March 2026

Amtek Laboratories Limited is a public limited company based in New Delhi, Delhi, India. It specialises in chemical distribution and retail, a part of the broader chemicals and materials sector. Incorporated on 24 November 1994, the company has been in operation for over 32 years.

Registered with ROC Delhi under CIN U74899DL1994PLC062969.

Capital: an authorised share capital of ₹22.7 Cr and a paid-up capital of ₹22.69 Cr. It is led by directors including Amman Kumar and Ashish Pandit.

Last AGM: 31 December 2020. Financial statements filed for year ended 31 March 2020. Office: D – 15 Pamposh Enclave Greater Kailash – 1, New Delhi, Delhi, India – 110048.

As per the financials filed for FY 2020, the company reported a revenue of ₹25.21 Lakh, a growth of 0% compared to the previous year.

As per MCA filings, the company has open charges of ₹10 Cr on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Amtek Laboratories Limited
CIN U74899DL1994PLC062969
Registration Number 062969
Incorporation Date 24 November 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Non-Compliant
Key People
Arvind Dham Whole-Time Director Amman Kumar Director Ashish Pandit Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    D – 15 Pamposh Enclave Greater Kailash – 1, New Delhi, Delhi, India – 110048
  • Industry
    Chemicals and Materials, Chemical Distribution & Retail
Company report
Amtek Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Amtek Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Amtek Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Amtek Laboratories Limited

Amtek Laboratories Limited is audited by PINTU & ASSOCIATES for the financial year 2019. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
PINTU & ASSOCIATES blur-value blur-value blur-value

Board of Directors of Amtek Laboratories Limited

Amtek Laboratories Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Amman Kumar
Also directs: Symbios Personnel Advices And Services Limited, Xlnc Advisory Services Private Limited, W.L.D. Investments Private Limited and 2 more
Director 01 Jul 2011 15 Years 0 Months Current
Ashish Pandit
Also directs: Gondwana Ispat Limited, Kac Casting Limited, Acl Industries Limited and 5 more
Director 30 Apr 2015 11 Years 2 Months Current
Arvind Dham
Also directs: Shivani Horticulture Private Limited, Kings Footwear India Private Limited, Quality Publicity Private Limited and 5 more
Whole-Time Director 01 Jul 2011 15 Years 0 Months Current
View all directors

Financials of Amtek Laboratories Limited FY 2020 filings available

Amtek Laboratories Limited reported revenue of ₹25.21 Lakh (up 0% YoY) for FY 2020. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹25.21 Lakh ▲ 0%
Profit
***** ▼ -180003%
EBITDA
***** ▼ -187245%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Amtek Laboratories Limited

As of FY 2019, Amtek Laboratories Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Amtek Laboratories Limited

Open charges
₹10 Cr
Satisfied charges
₹0
Breakdown by lending institutions
I.D.B.I. Bank Ltd.₹10.00 Cr
Latest charge details
DateLenderAmountStatus
07 Feb 1996 I.D.B.I. Bank Ltd. ₹10 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Amtek Laboratories Limited

View historical data on people associated with Amtek Laboratories Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Amtek Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Amtek Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Amtek Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Amtek Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Amtek Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Amtek Laboratories Limited

MSME Payment Delays by Amtek Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Amtek Laboratories Limited

Subsidiaries & Group Companies of Amtek Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Amtek Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Amtek Laboratories Limited

MCA Filings & Documents of Amtek Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Amtek Laboratories Limited

Activity
31 Dec 2020
Amtek Laboratories Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Activity
31 Mar 2020
Amtek Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi I.
Directors
30 Apr 2015
Ashish Pandit was appointed as a Director on 30 Apr 2015 & has been associated with this company since 11 years 2 months.
Directors
01 Jul 2011
Amman Kumar was appointed as a Director on 01 Jul 2011 & has been associated with this company since 15 years 12 days.
Directors
01 Jul 2011
Arvind Dham was appointed as a Whole-time director on 01 Jul 2011 & has been associated with this company since 15 years 12 days.
Charges
07 Feb 1996
A charge with I.D.B.I. Bank Ltd. amounted to Rs. 10.00 Cr with Charge ID 90041620 was registered on 07 Feb 1996.

Frequently Asked Questions about Amtek Laboratories Limited

Amtek Laboratories Limited is an active public limited company in the chemicals and materials sector based in New Delhi, Delhi, India. It was incorporated on 24 November 1994 (32+ years old) and is registered under CIN U74899DL1994PLC062969.

Amtek Laboratories Limited reported revenue of ₹25.21 Lakh for FY 2020 (up 0.00% YoY).

The current directors of Amtek Laboratories Limited are:

The primary industry of Amtek Laboratories Limited is chemicals and materials. The company specifically operates in chemical distribution and retail. The company is currently active in this sector.

Amtek Laboratories Limited can be reached at the registered office: D – 15 Pamposh Enclave Greater Kailash – 1, New Delhi, Delhi, India – 110048.

The authorised capital is ₹22.7 Cr, and the paid-up capital is ₹22.69 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available